A summary of survey results from ISPOR’s Annual North America meeting, where we gathered insights on important developments in the real world research space, including the impact of the 21st Century Cures Act on our industry.
THE INSIGHT SERIES: Do Late Phase Studies Offer Any Scientific Value? – Part 2
The growing focus on post-marketing and observational research has brought a heightened awareness, and scrutiny, on the design and execution of these…
21st Century Cures Act and Real-World Evidence
Join PRA in China
The expertise of a global CRO + local know-how to deliver the highest caliber of clinical development services around the world.